Clevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY)
Public ClinicalTrials.gov record NCT00369837. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of the Effect of Ultrashort-Acting Clevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY)
Study identification
- NCT ID
- NCT00369837
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- The Medicines Company
- Industry
- Enrollment
- 131 participants
Conditions and interventions
Conditions
Interventions
- clevidipine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2006
- Primary completion
- Dec 31, 2006
- Completion
- Jan 31, 2007
- Last update posted
- May 21, 2014
2006 – 2007
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Jackson Hospital | Montgomery | Alabama | 36106 | — |
| VA Medical Center W. LA | Los Angeles | California | 90073 | — |
| The George Washington University Medical Center | Washington D.C. | District of Columbia | 20037 | — |
| Louisiana State University Medical Center/Charity Hospital | New Orleans | Louisiana | 70118 | — |
| Critical Care Research Center at Louisiana State University Health Sciences Center | Shreveport | Louisiana | 71103 | — |
| Good Samaritan Hospital | Baltimore | Maryland | 21239 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Metrohealth Medical Center | Cleveland | Ohio | 44109 | — |
| The Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| The Toledo Hospital | Toledo | Ohio | 43606 | — |
| Providence Heart & Vascular Institute, d/b/a Providence St. Vincent Medical Center | Portland | Oregon | 97225 | — |
| Hamot Shock Trauma | Erie | Pennsylvania | 16550 | — |
| Pennsylvania Hospital | Philadelphia | Pennsylvania | 19107 | — |
| The University of Texas Health Science Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00369837, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 21, 2014 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00369837 live on ClinicalTrials.gov.